MedPath

A Study to Evaluate the Safety and Tolerability of a Nasal Spray to Treat Perennial Allergic Rhinitis

Phase 3
Completed
Conditions
Perennial Allergic Rhinitis
Interventions
Registration Number
NCT00720382
Lead Sponsor
Meda Pharmaceuticals
Brief Summary

The purpose of this study is to determine if one allergy treatment (0.15% azelastine hydrochloride) is as safe as mometasone furoate (nasonex) alone.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
703
Inclusion Criteria
  • Male and female patients 12 years and older with a compatible history greater than or equal to 1 year of rhinitis due to perennial allergies.
  • Must be willing and able to provide informed consent and to participate in all study procedures
  • Must be in generally good health
  • Positive skin test to a prevalent perennial allergen
Read More
Exclusion Criteria
  • On nasal examination, the presence of nasal mucosal erosion, nasal ulceration or nasal septal perforation
  • Use of any investigational drug within 30 days of the first visit
  • Any nasal surgery or sinus surgery within the previous year
  • Presence of any hypersensitivity to drugs similar to azelastine or mometasone furoate and to either sorbital or sucralose
  • Women who are pregnant or nursing
  • Women who are not using an acceptable method of birth control
  • Nasal Diseases likely to affect deposition of intranasal medication, such as sinusitis, rhinitis medicamentosa or clinically significant nasal polyposis or nasal structural abnormalities.
  • Asthma or other lung diseases such as COPD. Mild asthma symptoms may be considered after consultation with investigator.
  • Patients with Arrythmia
  • Patients with know history of alcohol and drug abuse
  • Existence of any surgical or medical condition, which in the opinion of the investigator or sponsor, might significantly alter the evaluation of the study.
  • Use of medications that could affect the study results
Read More

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
10.15% azelastine hydrochloride0.15% azelastine hydrochloride 1644 mcg
2Mometasone furoateMometasone furoate 200 mcg
Primary Outcome Measures
NameTimeMethod
Change From Baseline on Direct Visual Nasal Exams to 12 MonthsChange from baseline to 12 months

Examination of head and neck (scale: None, Mild, Moderate, Severe) for Epistaxis, Mucosal Edema, Nasal Discharge, Mucosal erythema, Mucosal Bleeding, and Crusting of mucosa. Nasal irritation was rated: 0 = None, Grade 1A = focal irritation, Grade 1B = superficial mucosal erosion, Grade 2 = moderate mucosal erosion, Grade 3 = ulceration, Grade 4 = septal perforation

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (58)

Allergy and Asthma DTC

🇺🇸

Tallahassee, Florida, United States

Allergy and Consultants of NJ/PA

🇺🇸

Collegeville, Pennsylvania, United States

Pharmaceutical Research & Consulting Inc

🇺🇸

Dallas, Texas, United States

Allergy and Clinical Immunology Associates

🇺🇸

Pittsburgh, Pennsylvania, United States

Asthma, Inc.

🇺🇸

Seattle, Washington, United States

AABI Associates Medical Group

🇺🇸

Fountain Valley, California, United States

Center of Research Excellence, LLC

🇺🇸

Oxford, Alabama, United States

West Coast Clinical Trials

🇺🇸

Long Beach, California, United States

Allergy Associates Medical Group Inc

🇺🇸

San Diego, California, United States

Allergy and Asthma Specialist Medical Group

🇺🇸

Huntington Beach, California, United States

Southern California Research

🇺🇸

Mission Viejo, California, United States

Allergy Research Foundation

🇺🇸

Los Angeles, California, United States

Allergy & Asthma Associates of Santa Clara Valley Research Cntr

🇺🇸

San Jose, California, United States

Allergy and Asthma Medical Group and Research Center

🇺🇸

San Diego, California, United States

Asthma and Allergy Associates

🇺🇸

Colorado Springs, Colorado, United States

Bensch Research Associates

🇺🇸

Stockton, California, United States

Allergy and Asthma Clinical Research, Inc.

🇺🇸

Walnut Creek, California, United States

Allergy and Asthma Care of Florida

🇺🇸

Ocala, Florida, United States

RX R+D

🇺🇸

Metairie, Louisiana, United States

Georgia Pollens Clinical Research Centers Inc

🇺🇸

Albany, Georgia, United States

Clinical Research Atlanta

🇺🇸

Stockbridge, Georgia, United States

Kansas City Allergy and Asthma

🇺🇸

Overland Park, Kansas, United States

Aeroallergy Research Laboratories of Savannah

🇺🇸

Savannah, Georgia, United States

Sneeze, Wheeze and Itch Associates

🇺🇸

Normal, Illinois, United States

Institute for Asthma and Allergy PC

🇺🇸

Wheaton, Maryland, United States

Asthma and Allergy Research Associate

🇺🇸

Upland, Pennsylvania, United States

Asthma, Nasal Disease & Allergy Research Center of New England

🇺🇸

Providence, Rhode Island, United States

Clinical Research Institute of Southern Oregon, PC

🇺🇸

Medford, Oregon, United States

Live Oak Allergy and Asthma Clinic

🇺🇸

San Antonio, Texas, United States

AARA Research Center

🇺🇸

Dallas, Texas, United States

Biogenics Research Institute

🇺🇸

San Antonio, Texas, United States

Sylvana Research Associates

🇺🇸

San Antonio, Texas, United States

Allergy Asthma Research Institute

🇺🇸

Waco, Texas, United States

Allergy, Asthma and Clinical Research Center

🇺🇸

Oklahoma City, Oklahoma, United States

Northeast Medical Research Associates

🇺🇸

North Dartmouth, Massachusetts, United States

Clinical Research Institute

🇺🇸

Plymouth, Minnesota, United States

The Asthma and Allergy Center

🇺🇸

Papillion, Nebraska, United States

Wake Research Associates, LLC

🇺🇸

Raleigh, North Carolina, United States

SWAAA Research Center

🇺🇸

Houston, Texas, United States

Allergy and Asthma Associates

🇺🇸

Austin, Texas, United States

VA Adult and Pediatric Allergy and Asthma

🇺🇸

Richmond, Virginia, United States

Allergy and Asthma Research NJ inc

🇺🇸

Mount Laurel, New Jersey, United States

The Clinical Research Center

🇺🇸

St. Louis, Missouri, United States

Atlantic Research Center

🇺🇸

Ocean, New Jersey, United States

Dr. Perin

🇺🇸

Teaneck, New Jersey, United States

Oklahoma Institute of Allergy and Asthma Clinical

🇺🇸

Edmond, Oklahoma, United States

Allergy Asthma and Dermatology Research

🇺🇸

Lake Oswego, Oregon, United States

Medical Research Associates of CNY, PLLC

🇺🇸

North Syracuse, New York, United States

Allergy and Asthma Specialist PC

🇺🇸

Blue Bell, Pennsylvania, United States

AAIR Research Center

🇺🇸

Rochester, New York, United States

North Carolina Clinical Research

🇺🇸

Raleigh, North Carolina, United States

New Horizon's Clinical Research

🇺🇸

Cincinnati, Ohio, United States

Bernstein Clinical Research Center

🇺🇸

Cincinnati, Ohio, United States

National Allergy, Asthma and Urticaria of Charleston

🇺🇸

Charleston, South Carolina, United States

Central Texas Health Research

🇺🇸

New Braunfels, Texas, United States

Las Vegas Physicians Research Group

🇺🇸

Henderson, Nevada, United States

Western Sky Medical Research

🇺🇸

El Paso, Texas, United States

Advanced Healthcare

🇺🇸

Milwaukee, Wisconsin, United States

© Copyright 2025. All Rights Reserved by MedPath